Pharmacovigilance of biosimilars - Why is it different from generics and innovator biologics?
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Postgraduate Medicine"
DOI: 10.4103/jpgm.jpgm_651_19
Abstract: The invent of biosimilar compounds has revolutionized the access of biological drugs to the patients for various indications. Oza et al., in their review, have narrated the differences in pharmacovigilance of biosimilar compounds as compared… read more here.
Keywords: biosimilar compounds; medicine; biosimilar agents; innovator ... See more keywords